Effectiveness of a Pain Management Programme
The Effectiveness of a Pain Management Programme for Patients With Persistent Pain
1 other identifier
observational
8
1 country
2
Brief Summary
Persistent pain (PP) affects many people worldwide. Patient Education is central to good management. Pain neurophysiology education (PNE) is a new form of education. It aims to help patients 'reconceptualise' their understanding of pain away from the perception that PP is an indicator of tissue damage, to PP is due to a sensitised nervous system. This perception is considered a less threatening and more conducive to rehabilitation. There is a growing body of evidence supporting its effectiveness. One unpublished Australian study combined PNE with a pain management program and found significant beneficial effects. However, there is a need to test this intervention rigorously under randomised controlled trial conditions to inform clinical practice. The Medical Research Council state that during the development and evaluation of a complex intervention (in this case a PNE informed PMP), it is important to undertake feasibility work, to investigate the components of randomised controlled trial (RCT) methodology prior to a full scale trial. The overarching aim of this mixed-methods study is to develop a feasible research protocol for a RCT investigating the efficacy of a pain neurophysiology education informed pain management programme. In this feasibility study, participants with PP will be assessed before and after a PNE informed pain management program that they are due to receive as part of their usual care. In the week before the programme participants will attend Teesside University (TU) where they will complete a battery of outcome measures. A subsample of participants will also undergo a semi-structured interview. In the week following completion of their usual care PMP participants will once again attend TU where they will complete the same outcome measures and the same subsample of participants will undergo a second semi-structured interview. At this point participants will have completed the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2017
CompletedFirst Posted
Study publicly available on registry
May 15, 2017
CompletedStudy Start
First participant enrolled
June 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2019
CompletedOctober 26, 2018
October 1, 2018
1.7 years
May 3, 2017
October 25, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
The Brief Pain Inventory (Short Form)
Change from pre intervention (week 0) to post intervention (week 9)
Secondary Outcomes (27)
Centre of pressure
Change from pre intervention (week 0) to post intervention (week 9)
Fifty-foot walk at fastest speed
Change from pre intervention (week 0) to post intervention (week 9)
Repeated sit-to-stand
Change from pre intervention (week 0) to post intervention (week 9)
The Pain Catastrophising Scale
Change from pre intervention (week 0) to post intervention (week 9)
Neurophysiology of Pain Questionnaire
Change from pre intervention (week 0) to post intervention (week 9)
- +22 more secondary outcomes
Eligibility Criteria
Patients with persistent musculoskeletal pain of greater than six months duration who have been referred to the pain management programme at James Cook University Hospital.
You may qualify if:
- Have capacity to give informed consent
- + years of age
- Have had pain that has persisted for greater than six months
- Have been referred to the pain management programme at James Cook University Hospital.
You may not qualify if:
- Pain arising from a non-musculoskeletal origin such as cancer pain, visceral pain or post stroke pain
- Have worsening neural signs
- Anyone being treated by or who has been treated by the researcher (JW)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Teesside Universitylead
- South Tees Hospitals NHS Foundation Trustcollaborator
Study Sites (2)
Teesside University
Middlesbrough, North Yorkshire, TS1 3BX, United Kingdom
The Pain Clinic, South Tees Hospitals NHS Foundation Trust
Middlesbrough, North Yorkshire, TS4 3BW, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
May 3, 2017
First Posted
May 15, 2017
Study Start
June 28, 2017
Primary Completion
March 8, 2019
Study Completion
March 8, 2019
Last Updated
October 26, 2018
Record last verified: 2018-10